Investor Relations


Stock Quote (NASDAQ: PODD)

Price:
41.94
Change:
+ 0.34
Day High:
42.17
Day Low:
41.33
Volume:
482,999
4:00 PM ET on Aug 26, 2016
Delayed ~20 min. By eSignal.
Stock price graph
     

Corporate Profile

Insulet Corporation is an innovative medical device company based in Billerica, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional..More ▼

View all »   RSSRecent Releases

Aug 3, 2016
Insulet Reports Second Quarter 2016 Financial Results

Aug 1, 2016
Insulet Corporation to Present at Upcoming Investor Conferences

View all »Events & Presentations

Sep 12, 2016 at 2:15 PM ET
The Morgan Stanley Global Healthcare Conference
Webcast Listen to webcast